Rare Cases of Multidrug-resistant Tuberculous Spondylitis in Saiful Anwar General Hospital: A Case Series
DOI:
https://doi.org/10.3889/oamjms.2021.7046Keywords:
Spine, Multidrug-resistant, Tuberculosis, Spondylitis, Chemotherapy, SurgeryAbstract
BACKGROUND: Ten percent of all tuberculosis patients may develop skeletal involvement, and the spine is the most common anatomical location. Tuberculous spondylitis is further complicated by the fast-acid bacilli resistance to the usual chemotherapy regimen (multidrug-resistant/MDR) and its complications. In this case series, we would like to present three MDR tuberculous spondylitis cases effectively treated with tailored chemotherapy regimens and surgical interventions.
CASE REPORT: A series of three patients with MDR tuberculous spondylitis is presented. All three patients presented with back pain, lump, and weakness of both lower extremities. These cases were resolved with a combination of surgical intervention and tailored chemotherapy regiment after MDR resistant detected. Two cases were resolved completely, and only one patient had residual paresthesia on his legs.
CONCLUSION: A combination of MDR antituberculous chemotherapy and surgical intervention leads to an excellent outcome, in which the patient can perform regular daily tasks without pain, even in complicated MDR tuberculous spondylitis cases.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Khanna K, Sabharwal S. Spinal tuberculosis: A comprehensive review for the modern spine surgeon. Spine J. 2019;19(11):1858-70. https://doi.org/10.1016/j.spinee.2019.05.002 PMid:31102727 DOI: https://doi.org/10.1016/j.spinee.2019.05.002
Li L, Zhang Z, Luo F, Xu J, Cheng P, Wu Z, et al. Management of drug-resistant spinal tuberculosis with a combination of surgery and individualised chemotherapy: A retrospective analysis of thirty-five patients. Int Orthop. 2012;36(2):277-83. https://doi.org/10.1007/s00264-011-1398-0 PMid:22065055 DOI: https://doi.org/10.1007/s00264-011-1398-0
Viswanathan VK, Subramanian S. Pott Disease (Tuberculous Spondylitis). Treasure Island, FL: Stat Pearls; 2019. p. 1-11.
Arockiaraj J, Karthik R, Michael JS, Amritanand R, David KS, Krishnan V, et al. ‘Need of the hour’: Early diagnosis and management of multidrug resistant tuberculosis of the spine: An analysis of 30 patients from a ‘high multidrug resistant tuberculosis burden’ country. Asian Spine J. 2019;13(2):265-71. https://doi.org/10.31616/asj.2018.007 PMid:30669824 DOI: https://doi.org/10.31616/asj.2018.0073
Zhang Y, Yew W. Mechanisms of drug resistance in Mycobacterium tuberculosis: Update 2015. Int J Tuberc Lung Dis. 2015;19:1276-89. https://doi.org/10.5588/ijtld.15.0389 PMid:26467578 DOI: https://doi.org/10.5588/ijtld.15.0389
Upadhyay M, Patel J, Kundnani V, Ruparel S, Patel A. Drug sensitivity patterns in Xpert-positive spinal tuberculosis: An observational study of 252 patients. Eur Spine J. 2020;29(7):1476-82. https://doi.org/10.1007/s00586-020-06305-x PMid:32055960 DOI: https://doi.org/10.1007/s00586-020-06305-x
Soeroto AY, Lestari BW, Santoso P, Chaidir L, Andriyoko B, Alisjahbana B, et al. Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study. PLoS One. 2019;14(2):e0213017. https://doi.org/10.1371/journal.pone.0213017 PMid:30818352 DOI: https://doi.org/10.1371/journal.pone.0213017
Held MF, Hoppe S, Laubscher M, Mears S, Dix-Peek S, Zar HJ, et al. Epidemiology of musculoskeletal tuberculosis in an area with high disease prevalence. Asian Spine J. 2017;11(3):405-11. https://doi.org/10.4184/asj.2017.11.3.405 PMid:28670408 DOI: https://doi.org/10.4184/asj.2017.11.3.405
Rajasekaran S, Soundararajan DC, Shetty AP, KannaRM. Spinal tuberculosis: Current concepts. Global Spine J. 2018;8 Suppl4:96S-108S.https://doi.org/10.1177/2192568218769053 PMid:30574444 DOI: https://doi.org/10.1177/2192568218769053
Perno JR, Gordon A, Roach N. In: Solomon TE, editor. Osteomyelitis. Ch. 41. Philadelphia, PA: Mosby; 2011. p. 283-90. DOI: https://doi.org/10.1016/B978-0-323-06794-2.00041-9
Rathod T, Sathe A, Kolur S. Multidrug-resistant tuberculosis of lumbosacral spine producing extensive destruction with lumbosacral kyphosis. BMJ Case Rep. 2020;13(5):e234246. https://doi.org/10.1136/bcr-2020-234246 PMid:32414775 DOI: https://doi.org/10.1136/bcr-2020-234246
Kemenkes RI. Peraturan Menteri Kesehatan Republik Indonesia No. 67. Indonesia: Kemenkes RI; 2016.
Pandita A, Madhuripan N, Pandita S, Hurtado RM. Challenges and controversies in the treatment of spinal tuberculosis. J Clin Tuberc Other Mycobact Dis. 2020;19:100151. https://doi.org/10.1016/j.jctube.2020.100151 PMid:32154388 DOI: https://doi.org/10.1016/j.jctube.2020.100151
Kizilbash QF, Seaworth BJ. Multi-drug resistant tuberculous spondylitis: A review of the literature. Ann Thorac Med. 2016;11(4):233-6. https://doi.org/10.4103/1817-1737.191867 PMid:27803747 DOI: https://doi.org/10.4103/1817-1737.191867
Tuli SM. Challenge of therapeutically refractory and multidrug resistant tuberculosis in orthopaedic practice. Indian J Orthop. 2002;36(4):211-3.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Syaifullah Asmiragani, Tjuk Risantoso, Andhika Yudistira, Ery Satriawan, Albert Lesmana, Alva Pribadi, Lasa Dhakka Siahaan (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
